More on SABS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.3 Score)

Upcoming Events

- Earnings (8/6/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

SAB Biotherapeutics (NQ:SABS)
Delayed: 4.00 +0.14 (3.63%)
Prev. Close $3.86  
Open$3.93 
52 Wk High$ 
52 Wk Low$ 
Day High$4.10 
Day Low$3.85 
P/E N/A  
EPS$ 
Volume2,908,295 

Friends, Peers and Foes (?): SABSW (more...)

Jun 18, 2026 04:35 PM Form 8-K SAB Biotherapeutics, For: Jun 18
Jun 15, 2026 02:31 PM SAB Biotherapeutics (SABS) PT Raised to $13 at Jefferies
May 22, 2026 05:08 AM Citi Starts SAB Biotherapeutics (SABS) at Buy
May 20, 2026 03:18 AM Jefferies Starts SAB Biotherapeutics (SABS) at Buy
May 15, 2026 04:00 PM Form SCHEDULE 13G/A SAB Biotherapeutics, Filed by: PERCEPTIVE ADVISORS LLC
May 15, 2026 11:18 AM Form SCHEDULE 13G SAB Biotherapeutics, Filed by: Caligan Partners LP
May 15, 2026 06:36 AM Form SCHEDULE 13G SAB Biotherapeutics, Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 12, 2026 12:07 PM SAB Biotherapeutics (SABS) PT Raised to $10 at H.C. Wainwright
May 12, 2026 07:36 AM Form 10-Q SAB Biotherapeutics, For: Mar 31
May 12, 2026 07:30 AM SAB Biotherapeutics reports Q1 2026 results, enrollment progress
View All Articles

Entities mentioned with SABS

View All Entities